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Abstract
Understanding the dynamic relationship between components of a system or pathway at the individual cell level is a
current challenge. To address this, we developed an approach that allows simultaneous tracking of several endogenous
proteins of choice within individual living human cells. The approach is based on fluorescent tagging of proteins at their
native locus by directed gene targeting. A fluorescent tag-encoding DNA is introduced as a new exon into the intronic
region of the gene of interest, resulting in expression of a full-length fluorescently tagged protein. We used this approach to
establish human cell lines simultaneously expressing two components of a major antioxidant defense system, thioredoxin 1
(Trx) and thioredoxin reductase 1 (TrxR1), labeled with CFP and YFP, respectively. We find that the distributions of both
proteins between nuclear and cytoplasmic compartments were highly variable between cells. However, the two proteins
did not vary independently of each other: protein levels of Trx and TrxR1 in both the whole cell and the nucleus were
substantially correlated. We further find that in response to a stress-inducing drug (CPT), both Trx and TrxR1 accumulated in
the nuclei in a manner that was highly temporally correlated. This accumulation considerably reduced cell-to-cell variability
in nuclear content of both proteins, suggesting a uniform response of the thioredoxin system to stress. These results
indicate that Trx and TrxR1 act in concert in response to stress in regard to both time course and variability. Thus, our
approach provides an efficient tool for studying dynamic relationship between components of systems of interest at a
single-cell level.
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Introduction
Studying the dynamical relationship between different compo-
nents of a system or pathway is crucial for understanding how
proteins work together to generate cellular responses. A measure-
ment system for such studies needs to follow dynamical changes in
expression and localization of several proteins of interest over time
in the same individual cells. Working at the level of individual cells
is important due to cell-cell variability [1,2,3,4], which is masked
in assays based on averaging cell populations. Furthermore,
averaging approaches can miss some dynamical features of protein
behaviors, such as all-or-none effects [5] and oscillations [6,7,8,9],
as well as events that occur in only a subset of cells [10,11].
Quantitative time-lapse fluorescence microscopy offers the
advantage of tracking proteins in individual living cells over time
[12,13]. It requires usage of noninvasive fluorescent markers such
as genetically encoded fluorescent proteins. Proteins labeled with a
fluorescent tag tend to preserve the same half-lives [14,15,16],
dynamics and localizations [10,14,15,17,18,19] as their wild-type
counterparts. Multicolor time-lapse imaging of two or more
proteins, each tagged with a different fluorescent marker, provides
a powerful tool to determine functional relationships between
proteins within individual cells. Regulatory interactions can be
revealed by analyzing dynamic correlations in gene expression
fluctuations [20]. Spatial relationships between proteins within
particular subcellular compartments can be detected by co-
localization analysis, FRET and other approaches [21,22,23].
Multicolor live cell imaging is also especially useful for co-
localization analysis of soluble proteins, since it overcomes
potential concerns associated with cell fixation conditions [24].
Fluorescent tagging of proteins at the endogenous gene loci (rather
than exogenous expression) is advantageous, because it preserves
the native regulation of protein expression and avoids over-
expression concerns. In the present context, we aimed to generate
human reporter cell lines simultaneously expressing two endoge-
nous proteins of interest, each labeled with a different fluorescent
tag. Development of such multicolor reporter lines is challenging
due to constraints of current approaches for genetic manipulations
in human cells.
There are two major strategies for tagging endogenous proteins
in mammalian cells. One is Central Dogma (CD) tagging. In this
strategy, fluorescent tag-encoding DNA is introduced into
genomic loci as a new exon. The tagging DNA is integrated into
the genome in a random (non-directed) manner using a retrovirus
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tagging to create a Library of Annotated Reporter Cells (LARC) in
the H1299 human non-small lung carcinoma cell line [10,25,28].
Our LARC collection contains about 1200 cell clones, each
expressing a different, annotated full-length protein labeled
endogenously with a yellow fluorescent tag (YFP or Venus). It
was used to study variability of protein levels between cells [1,11],
the prevalence of cell-cycle dependent protein dynamics [28,29],
and the effects of a cancer drug on the proteome [10]. Detailed
information can be found in www.dynamicproteomics.net.
We also applied CD tagging to establish double-labeled reporter
cells, in which one protein is tagged with YFP and the other with a
red fluorophore, mCherry. This was achieved by two iterative
rounds of CD tagging [1]. Since the combination of the two
fluorescently labeled proteins in such reporter cells was based on
the random retrovirus insertion, the approach is not feasible for
targeting pre-selected genes.
The strategy that allows tagging proteins of interest is directed
gene targeting. This is based on introducing into the cell
exogenous DNA that contains regions of homology to the gene
of interest flanking a selectable marker gene, which is integrated
into the genome via homologous recombination. The most
common application of directed targeting is inactivation of alleles
of a gene of interest to generate knock-outs. The same strategy
could also be exploited to introduce sequences into an endogenous
gene, creating a knock-in allele. While routinely applied to diverse
model organisms such as bacteria, yeast and rodents, application
of directed gene targeting to human cells is much less efficient due
to a lower rate of homologous recombination in human somatic
cells [30,31]. Recent advances in this area, such as utilization of
recombinant Adeno-Associated Virus (rAAV) for delivery of
targeting DNA [32,33,34] and use of promoterless configuration
of selection markers [35,36] made gene targeting in human cells
more feasible. Up to date, tagging of endogenous proteins in
human somatic cells by directed gene targeting has been
performed primarily with short tag sequences, such as the FLAG
epitope [37,38]. Knock-in of large sequences, such as fluorescent
protein sequences, has been used to report for endogenous
promoter activity/gene expression [39] but not for protein
tagging.
Here we present an approach for fluorescent labeling of
endogenous proteins in human cells by directed gene targeting.
In this approach, termed ‘‘directed CD tagging’’, fluorescent
protein-encoding DNA is introduced into desired genomic locus as
an artificial exon. This exon is then spliced into the gene’s mRNA
to produce a full-length in-frame fusion protein. Iterative rounds of
directed CD tagging using different fluorescent tags allow labeling
several pre-selected proteins to study their dynamical relationship
in vivo.
To test this strategy we chose the thioredoxin system
[40,41,42,43,44], which plays a critical role in regulation of
cellular redox homeostasis and cell defense against oxidative stress.
This system is well studied, and both of its key proteins in single-
tagged form are available in the LARC library. The main
components of the system are oxidoreductase enzymes thioredoxin
1 (Trx) and thioredoxin reductase 1 (TrxR1). Trx reduces and
thereby supports the activity of numerous proteins including
ribonucleotide reductase, transcription factors and antioxidant
peroxiredoxines. When reducing oxidized protein substrates, Trx
itself becomes oxidized, and TrxR1 functions to recycle Trx back
to the reduced (active) form. Both Trx and TrxR1 are ubiquitously
expressed and reside predominately in cytosol. Upon exposure of
cells to agents causing intracellular elevation of reactive oxygen
species (ROS), Trx translocates from the cytosol into the nucleus
[45,46,47,48,49,50,51], where it activates redox-sensitive tran-
scription factors including NF-kappaB [52,53], AP1 [54], p53
[55], Nrf2 [56], HIF [57] and others, which in turn activate
expression of stress-responsive genes.
We applied directed CD tagging to label the Trx protein with a
cyan fluorescent tag (CFP) in the LARC clone expressing the
TrxR1-YFP fusion protein. The resulting double-labeled reporter
cells allowed comparison of dynamical behaviors of Trx-CFP and
TrxR1-YFP in individual living cells and were used to study the
dynamics and cell-cell variability of the thioredoxin system. We
found sizable variability across the cells in timing, expression and
localization of the system’s components. However, this variability
was correlated between the two proteins, so that they seemed to
vary together to a large extent. Correlation in spatio-temporal
dynamics of the two proteins was most prominent in response to a
drug-induced stress.
Results
Fluorescent labeling of endogenous proteins by directed
CD tagging: a method overview
We combined ideas from CD tagging and directed gene
targeting to develop a method for directed fluorescent labeling of
endogenous proteins in human cells. We applied this to cells from
the H1299 LARC library to generate double-labeled reporter cell
lines. We used the LARC library, because it contains over a
thousand clones expressing different endogenous YFP-labeled
proteins. To create double-labeled cells, a pre-chosen LARC clone
expressing a desired YFP-tagged protein was used as a parental
line, onto which another protein of interest (e.g. from the same
biological pathway) was tagged with a Cyan Fluorescent Protein
(CFP) by directed gene targeting. For CFP-tagging we used the
monomeric form of an improved variant of CFP, Cerulean [58].
For simplicity, monomeric Cerulean will be further referred to as
CFP.
The tagging procedure is outlined in Figure 1B. The CFP-
encoding DNA sequence is introduced into gene locus of interest
by means of homologous recombination mediated by recombinant
Adeno-Associated Virus (rAAV). As shown in Figure 1A, the CFP-
tagging rAAV targeting construct contains two regions of
homology to an intronic sequence of the target gene, flanking
the CFP cassette. Similarly to CD-tagging, our targeting approach
uses an artificial exon strategy: the CFP cassette in the targeting
vector consists of the CFP-coding sequence (with no start and stop
codons) flanked by splice acceptor and donor sequences. When
integrated into the intronic region of the target gene, the artificial
exon is spliced into the gene’s mRNA, and a full-length fusion
protein is translated (Figure 1A). Expression of the fluorescent tag
from the native chromosomal location depends on production of
an in-frame fusion protein. Thus, the fluorescent protein serves as
both a reporter tag and a promoterless selection marker. The
CFP-positive knock-in cells are selected by flow cytometric single-
cell sorting. It should be noted that tagged cells generated in this
way are heterozygous with respect to the CFP knock-in.
CFP tagging of Trx in the TrxR1-YFP LARC clone
The directed CD tagging approach was applied to tag the Trx
protein with CFP, in the LARC clone expressing the TrxR1-YFP
fusion protein. The CFP-tagging rAAV vector was designed to
target intron 3 of the thioredoxin 1 gene, TXN1 (Figure 1A).
The thioredoxin targeting vector was packaged into rAAV. The
TrxR1-YFP cell line was then infected with the targeting virus,
and CFP-expressing knock-in cells were selected by FACS. As seen
in Figure 1C, the fraction of CFP-positive cells was about 0.02%.
Protein Dynamics in Human Cell
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individual wells of 384-well plates. Since the proportion of CFP-
positive cells in the total population of infected cell is very low, the
percentage of false-positive events introduced by FACS during the
sorting stage is expected to be relatively high. Therefore, following
FACS sorting the cells were further screened for CFP expression
by fluorescence microscopy to detect true-positive events. Several
independent sorting experiments were performed. Typically, out
of 384 cells plated, about 100–120 (26–30%) survived the sorting
stage and formed colonies. Among these colonies, 3–12 clones (3–
10%) represented true-positive events and expressed CFP, as
detected by fluorescence microscopy. To summarize, FACS
sorting of ,7–8610
6 infected cells (an equivalent of 50%
confluent 15 cm plate) typically resulted in establishing of 3–12
CFP-positive (recombinant) clones. Thus, the overall efficiency of
the tagging procedure in H1299 cells is about 1610
26. The
established recombinant clones were further expanded and
screened for proper targeting.
To ascertain whether the CFP sequence in the recombinant
clones was present only within the thioredoxin gene transcript, the
identityofCFPlabeled RNAwasdeterminedbyrapidamplification
of cDNA 39end (39 RACE) and subsequent sequencing. The CFP
(mCerulean) primers utilized in the 39 RACE analysis were chosen
to avoid cross-reactivity with YFP. These primers, which spanned
CFP (mCerulean) nucleotides 432–451 and 606–626, were used in
the 1
st and 2
nd (nested) PCR amplifications, respectively (for details
see Materials and Methods section).
More than 20 recombinant clones were screened by 39 RACE.
Representative results are shown in the upper panel of Figure 2A.
While no PCR products were observed with the parental TrxR1-
YFP clone, for all recombinant clones, the 1
st and the 2
nd PCR
reactions uniformly yielded single-band products. The band of the
nested reaction was lower than that of the 1
st PCR by a nesting
distance of 174 bp. These results demonstrate that all recombinant
clones tested expressed only one CFP-tagged gene transcript.
Subsequent sequencing of 39RACE products further confirmed
that this transcript corresponds to Trx mRNA. Sequencing data
also confirmed a precise in-frame fusion of the CFP 39 end to the
exon 4 of Trx mRNA (a fragment of typical chromatogram
displaying the 39 fusion point is shown in Figure 2A, lower panel).
The correct fusion at the mRNA level indicates that the artificial
exon CFP cassette has been properly integrated into intron 3 of the
TXN1 gene.
Trx targeting was further validated at the mRNA level by RT-
PCR. Two screening approaches were used. The first employed
one PCR primer complementary to CFP and the second
complementary to the Trx exonic sequence located either
upstream or downstream of CFP (the primer positions are
schematically depicted in Figure 2B, upper panel). When using
these primers, the PCR product is amplified only from the CFP-
tagged Trx mRNA. Indeed, as shown in Figure 2B (right lower
panel), a single dominant PCR band of correct size was observed
in the recombinant clones, but not in the parental TrxR1-YFP
cells. The second RT-PCR screening approach utilized the
primers’ pair complementary to the first and to the last exon of
Trx. This approach resulted in amplification of two PCR products
in recombinant clones: a 414 bp-long band corresponding to the
wild-type (non-tagged) Trx mRNA and a 1128 bp-long band
Figure 1. Fluorescent labeling of endogenous proteins by directed CD tagging. A) Schematic diagram of the tagging approach. Insertion
of the CFP cassette into intron 3 of TXN1 is mediated by rAAV. Correct site-specific integration results in retaining CFP sequence as a new exon after
the splicing of mRNA. The tagged mRNA translates to the internally labeled Trx protein. ITR, inverted terminal repeat; HA, homologous arm; SA,
splicing acceptor, SD, splicing donor; CFP seq, CFP sequence; E, exon. B) Flow chart of the tagging procedure. C) Selection of recombinant (CFP-
positive) cells by FACS. FACS histograms are shown for the control H1299 cells, the parental TrxR1-YFP clone and the TrxR1-YFP cells infected with
Trx-CFP rAAV. The P1 region of the plot indicates the YFP-positive cells, the P2 region indicates the sorting gate used for selection of the CFP-positive
portion of the infected TrxR1-YFP cells.
doi:10.1371/journal.pone.0013524.g001
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sequence is 714 bp in size). In the parental TrxR1-YFP clone only
a 414 bp product was amplified (Figure 2A, left lower panel).
To summarize, 39RACE and RT-PCR analyses demonstrated
that CFP-tagging was unique, specific and correct in all clones
tested. Thus, our method can readily yield productive cell lines
from rare but precise recombination events.
Validation of expression of the Trx-CFP and TrxR1-YFP
fusion proteins in Trx-CFP/TrxR1-YFP reporter cells
The expression of full-length Trx-CFP and TrxR1-YFP fusion
proteins in Trx-CFP/TrxR1-YFP double-labeled reporter cells
was further tested by immunoblotting. Molecular weights of the
non-tagged TrxR1 and Trx proteins are ,55 kDa and ,13 kDa,
respectively. Addition of the YFP/CFP tag increases the proteins’
weight by ,27–30 kDa. As shown in Figure 2C (upper panel), the
full-length TrxR1-YFP and Trx-CFP fusion proteins (MW
,84 kDa and ,42 kDa, respectively) were recognized by anti-
GFP antibody. Anti-TrxR1 and anti-Trx antibodies also recog-
nized the corresponding fusion protein, together with its wild-type
counterpart expressed from the untagged alleles (Figure 2C, the
middle and the lower panels). Immunoblot analysis with protein-
specific antibodies indicated that the protein bands corresponding
to either TrxR1-YFP or Trx-CFP were about 2-fold less intense
than those corresponding to the non-tagged proteins. This suggests
that the tagged and non-tagged TrxR1 and Trx are expressed at a
ratio of about 1:2. These results are consistent with previous
kariotyping data which showed that parental H1299 cells have
three copies of both chromosome 12, containing the thioredoxin
reductase 1 gene, and chromosome 9, containing the thioredoxin1
gene (data not shown), of which only one copy is expected to be
tagged. These results suggest that both TrxR1 and Trx proteins
are expressed from the tagged allele at about the same level as
from the untagged alleles.
Figure 2. Test of proper targeting and expression of Trx-CFP. A)3 9RACE and sequencing. The upper panel shows 39RACE results for three
representative CFP-tagged clones (Trx-CFP/TrxR1-YFP) and for the control parental TrxR1-YFP cells. First lane (1) indicates first PCR and second lane (2)
indicates the nested PCR for each clone. The PCR products obtained for the TrxR1-YFP/Trx-CFP clones were further subjected to sequencing. The
lower panel shows a fragment of representative sequencing chromatogram. The correct fusion of the 39 end of CFP sequence to the beginning of the
Trx exon 4 is indicated. B) RT-PCR analysis. The CFP-tagged Trx mRNA is schematically depicted on the upper panel. Positions of the primers used for
RT-PCR are designated by arrows. The lower panel shows representative RT-PCR results for two Trx-CFP/TrxR1-YFP clones and for the parental TrxR1-
YFP clone. The primer pairs used for each reaction are indicated in the bottom. Positions of the PCR products corresponding to the wild-type (non-
tagged) and to the CFP-tagged Trx mRNA are denoted by arrows. C) Immunoblot analysis. The control H1299 cells, the parental TrxR1-YFP clone and
the Trx-CFP/TrxR1-YFP double-labeled cells were immunoblotted (IB) with anti-GFP,-TrxR1 and -Trx antibodies. Bands corresponding to the wild-type
and tagged proteins are marked by arrows.
doi:10.1371/journal.pone.0013524.g002
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living cells reveals high variability in nuclear levels of
both proteins
To determine protein levels and localizations of Trx-CFP and
TrxR1-YFP in individual living cells we employed time-lapse
fluorescence microscopy under controlled CO2, temperature and
humidity, as described in Cohen et al. [10]. Fluorescent images
were analyzed using automated image analysis software (see
Materials and Methods). Cell segmentation was achieved by
means of a third fluorophore, mCherry (red). This tag was
introduced by CD tagging into parental H1299 cells prior to the
LARC library construction, and is common to all LARC clones.
mCherry is integrated into genomic sequences of two proteins:
XRCC5, localized to the nucleus, and DAP1, localized mainly to
the cytoplasm. Expression of these two tagged proteins creates a
mCherry fluorescence pattern which is bright in the nucleus and
dimmer in the cytosol. This pattern allows automated detection of
cellular and nuclear boundaries (Figure 3A, lower panel) [10].
As shown in Figure 3A (upper panel), Trx-CFP and TrxR1-YFP
are localized to both cell nuclei and cytoplasm. This is consistent
with subcellular distribution of Trx and TrxR1 reported for non-
small cell lung carcinomas [59].
Image analysis allowed accurate quantification of Trx and
TrxR1 protein levels in the whole cell and in the nucleus, defined
as the total CFP/YFP fluorescence within the cell and nuclear
boundaries. On average, the nuclear fraction of Trx-CFP and
TrxR1-YFP comprised about 43% and 39%, respectively, of the
total protein levels. Variability was observed in both the levels and
subcellular distributions of Trx-CFP and TrxR1-YFP across
individual cells. The variability in total protein levels of Trx-
CFP and TrxR1-YFP was comparable to that of the Cherry-
tagged proteins (Figure 3B). The average ratio between fluores-
cence of the 90
th percentiles of the cells to the 10
th percentiles of
the cells (90:10 ratio) was 2.360.3 for Trx-CFP, 2.460.3 for
TrxR1-YFP and 2.160.24 for Cherry. Similarly, the average
coefficient of variation (CV=standard deviation/mean) was
0.4160.08 for Trx-CFP, 0.4460.06 for TrxR1-YFP and
0.3560.04 for Cherry (Figure 3B). This level of variability is
comparable to that found in other proteins in human cells [1,11].
Variability in nuclear levels of both Trx-CFP and TrxR1-YFP was
considerably higher than that of Cherry (Figure 3B). Thus, the
average 90:10 ratio of nuclear fluorescence was 3.160.6 and
3.860.4, for Trx-CFP and TrxR1-YFP respectively, and
2.260.23 for Cherry. CV of nuclear fluorescence for Trx-CFP
and TrxR1-YFP was 0.6560.14 and 0.7560.08, respectively, and
these values were about 2-fold higher than the CV of Cherry
(Figure 3B). This heterogeneity in nuclear levels of Trx-CFP and
TrxR1-YFP is clearly observable by eye and stems mainly from
cells that are highly enriched in nuclear Trx-CFP and TrxR1-YFP
relative to the rest of the population (Figure S1). In line with this
observation, presence of a cell fraction enriched in nuclear Trx has
been recently shown for the HUVEC cell line using immuno-
staining of fixed cells [60].
Both total and nuclear levels of Trx-CFP and TrxR1-YFP
within individual cells were substantially correlated. The correla-
tion between Trx-CFP and TrxR1-YFP is discussed below.
Trx and TrxR1 localize to the nucleus in response to CPT
It has been previously shown that exposure of cultured cells to
agents causing elevation of intracellular reactive oxygen species
(ROS) results in translocation of Trx from the cytoplasm to the
nucleus [47,49,51,53]. This translocation is suggested to be a
hallmark of oxidative stress response [51].
Generation of Trx-CFP/TrxR1-YFP reporter cells allows
studying the dynamical relationship between components of the
thioredoxin system within the same cells during their response to
oxidative stress. For such experiments we chose to use campto-
thecin (CPT). CPT evokes oxidative stress [61,62], has been used
in our previous studies of proteome’ dynamics, and was shown to
induce nuclear translocation of both TrxR1 and Trx, present in
the LARC library as YFP fusion proteins [10].
Figure 3. Individual cell measurements show high variability in
nuclear levels of Trx-CFP and TrxR1-YFP. A) Fluorescent and
phase-contrast images of Trx-CFP/TrxR1-YFP reporter cells. mCherry
fluorescence is used for automated detection of cellular and nuclear
boundaries. Scale bar denotes 20 microns. B) The cell-to-cell variability
in Trx-CFP and TrxR1-YFP nuclear levels is significantly higher than the
variability observed for the whole cell protein content. The coefficient
of variance (CV) represents the ratio between standard deviation and
mean. Error bars denote standard error.
doi:10.1371/journal.pone.0013524.g003
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followed dynamics of Trx-CFP and TrxR1-YFP in individual
cells upon addition of 10 mM CPT to the cell medium. Time-lapse
movies were acquired for a period of 30–40 hours, at a temporal
resolution of 20 min. Each movie allowed tracking of individual
cells from 48 fields of view; each field of view contained 50–100
cells (for more details see Material and Methods section). Relative
error of the average fluorescence measurements between day-to-
day repeats was about 15%. The protein response to CPT was
analyzed for the first 25 hours; after this time point accumulation
of dead cells precluded precise analysis.
We found that upon CPT exposure both Trx-CFP and TrxR1-
YFP gradually accumulated in the cell nuclei (see Movies S1 and
S2, and Figure 4A). On average, CPT stimulation for 25h resulted
in about 2-fold increase in nuclear levels of both proteins
(1.7860.1 for Trx-CFP and 1.9560.12 for TrxR1-YFP). No
significant CPT-induced nuclear accumulation was found for the
Cherry-tagged proteins (See Movie S3 and Figure 4A). Likewise,
in the control mock-treated cells no nuclear increase was observed
for Trx-CFP and a small ,1.2-fold increase was observed for
TrxR1-YFP (Figure 4B).
No significant correlation (Spearman R,0.15) was found
between the initial nuclear level (Fi) of either Trx-CFP or
TrxR1-YFP and the amplitude of their nuclear accumulation
following CPT addition (Fmax-Fi) (Figure S2A, B). Moderate anti-
correlation was observed between the initial nuclear level (Fi) and
the ratio of CPT-induced nuclear rise (Fmax/Fi) of either protein
(R=20.41, p,0.0001 for Trx and R=20.3, p,0.0001 for
TrxR1) (Figure S2C, D). The CV of nuclear levels for both
proteins decreased upon CPT treatment by more than 30%
Figure 4. Nuclear accumulation of Trx-CFP and TrxR1-YFP in response to CPT. A) Nuclear fluorescence profile of Trx-CFP, TrxR1-YFP and
Cherry following CPT treatment. The upper panel shows fluorescent images of a representative cell expressing Trx-CFP and TrxR1-YFP. Time after CPT
addition is indicated above each image. The lower panel: thin lines denote nuclear fluorescence of individual cells normalized to their initial nuclear
fluorescence prior to the drug addition (time 0). Bold lines represent the normalized average nuclear fluorescence. B) Increase in nuclear fluorescence
of Trx-CFP and TrxR1-YFP is caused by CPT. Yellow and cyan lines correspond to the normalized average nuclear fluorescence of TrxR1-YFP and Trx-
CFP, respectively. Full and open circles denote nuclear fluorescence in CPT- and mock-treated cells, respectively. Error bars represent standard error of
at least three independent experiments. C) Cell-to-cell variability in nuclear fluorescence of both Trx-CFP and TrxR1-YFP decreases upon CPT addition.
CV of nuclear fluorescence of TrxR1-YFP (yellow line), Trx-CFP (cyan line) and Cherry (red line) was calculated for 25h following CPT addition. Error
bars denote standard error.
doi:10.1371/journal.pone.0013524.g004
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the variability in nuclear levels of Trx/TrxR1 between cells.
In contrast to the nuclear accumulation observed following
CPT addition, the total amounts of Trx-CFP and TrxR1-YFP did
not vary significantly (Figure S3A), while the cytoplasmic levels of
both proteins slightly decreased (Figure S3B). Also, no substantial
changes in cell-to-cell variability in total amounts and cytoplasmic
levels of the two proteins were observed (change in CV,20%)
(Figure S3C, D).
We also measured nuclear enrichment defined as the ratio of
nuclear fluorescence to total cell fluorescence. Similarly to the
nuclear protein levels, nuclear enrichment increased in response to
CPT by 2 fold for TrxR1-YFP and by 1.5 fold for Trx-CFP. The
cell-to-cell variability in nuclear enrichment of both proteins
decreased following CPT addition by more than 40% (Figure S4),
again indicating that after CPT exposure the cells become more
similar in their protein distribution profile.
Trx-CFP and TrxR1-YFP are reliable reporters for nuclear
accumulation of the wild-type endogenous Trx and
TrxR1
It should be noted that the present study does not require the
tagged proteins to be functional, but merely to be reliable reporters
for the dynamics and localization of the endogenous proteins. As
reported previously, the majority of endogenous proteins labeled
internally with a fluorescent tag preserve their wild-type
localizations and functions [17,18,19]. In our recent work we
found that ,80% of the endogenously tagged proteins from the
LARC library serve as faithful markers for the dynamics of
endogenous proteins [10]. In Trx-CFP/TrxR1-YFP cells the CFP
tag is inserted between aa 63 and 64 of the Trx protein, leaving its
catalytic site -CGPC- (aa 32–35) intact. The YFP tag is integrated
between aa 3 and 4 of TrxR1, preceding the sites required for the
TrxR1 catalytic activity.
We compared the dynamics of Trx-CFP from the Trx-CFP/
TrxR1-YFP cells and of Trx-YFP from the LARC clone
160507pl1F3 (the YFP tag is inserted between Trx aa 8 and 9), in
which TrxR1 is not tagged. Dynamics of CPT-induced nuclear
enrichment for both Trx-CFP and Trx-YFP were quite similar
(Figure S5A). Likewise, dynamics of TrxR1-YFP from either Trx-
CFP/TrxR1-YFP cells or the parental LARC clone 010506pl1A12
or of TrxR1-YFP from the LARC clone 130207pl1E3, generated
by an independent round of CD-tagging, were nearly identical
(Figure S5B).
We further tested whether the wild-type endogenous Trx and
TrxR1 proteins localize to the nucleus upon CPT exposure. The
H1299 cells expressing non-tagged Trx and TrxR1 were fixed at
0, 10 and 25 hours following CPT treatment and immunostained
with two different pairs of anti-Trx and anti-TrxR1 antibodies.
We found that following CPT addition both the wild-type Trx and
TrxR1 proteins localized to the cell nuclei with dynamics similar
to those observed for the fluorescently labeled Trx and TrxR1
(Figure 5).
We also treated the cells with H2O2, a classical inducer of
oxidative stress. Using time-lapse microscopy we observed a
considerable rise in nuclear levels of both Trx-CFP and TrxR1-
YFP following H2O2 addition (Figure 6A). Nuclear accumulation
was also observed in the H1299 cells fixed at 6 h after H2O2
exposure and immunostained for the endogenous Trx and TrxR1
proteins (Figure 6B, C).
Taken together, these results indicate that Trx-CFP and TrxR1-
YFP are reliable reporters for dynamical localization changes of
the wild-type Trx and TrxR1.
Trx and TrxR1 show correlated dynamics
The basal levels of Trx and TrxR1 were substantially correlated
(R=0.6460.05, p,0.0001 for total cell levels and R=0.6260.04,
p,0.0001 for nuclear levels). Interestingly, nuclear enrichment
showed the highest correlation (R=0.8760.02, p,0.0001). The
correlation between Trx and TrxR1 was significantly higher
than the correlation observed with the Cherry-tagged proteins
(Figure S6).
We next asked whether dynamics of Trx and TrxR1 in response
to CPT are correlated as well. We found that during the 25 hours
following CPT addition the correlation values observed for the
basal protein levels slightly decreased (Figure 7A). Nuclear
enrichment, which represents the dynamical changes in protein
localization, remained the most correlative measure.
To further study the relationship of the Trx and TrxR1
dynamics, we calculated the cross correlation function r(t) (see
Methods) for both total cell fluorescence and nuclear enrichment
under several conditions. The de-correlation time between the
dynamics of the two proteins was defined as the time it takes for
r(t) to decay by 50% (t50). Longer de-correlation times represent
stronger correlation between the two proteins. We found that
under non-stimulated conditions (unsynchronized cells and cells
synchronized to cell cycle in-silico (See Methods)) the decay time
was relatively short: t50 =1.5–2 hours for both total cell protein
fluorescence and nuclear enrichment measurements. However,
upon CPT addition the decay time of the cross correlation
increased to 3.5 hours for total cell fluorescence and to 6 hours for
nuclear enrichment (Figure 7B). Thus, again, nuclear enrichment
upon CPT treatment was the most correlative measure.
To further study the dynamical relationship of the two proteins
we defined for each cell T50TrxR1-YFP and T50Trx-CFP as the
time it takes for either protein to reach half of the nuclear level
observed 25 hours following CPT addition. We found that
T50TrxR1-YFP and T50Trx-CFP varied between cells in a way
that was highly correlated (R=0.71, p,0.0001; Figure 7C). Only
mild correlation was found between either T50TrxR1-YFP or
T50Trx-CFP and T50 of Cherry-tagged proteins (R#0.23,
p,0.001) (Figure S7). No dependence was found between the
basal nuclear levels of each TrxR1-YFP and Trx-CFP and their
T50 (Figure S8).
Taken together, these results imply that Trx and TrxR1
proteins respond in concert to CPT stimulation and that
correlative aspects of their dynamics are even more prominent
than those of their levels.
Discussion
A directed CD tagging method for fluorescent labeling of
endogenous proteins
We presented a feasible approach for fluorescent tagging of
endogenous proteins in human somatic cells. This is based on the
rAAV-mediated directed targeting of an intronic region of the
gene of interest with an artificial exon cassette containing a
fluorescent protein-coding sequence. We designed a generic
artificial exon CFP cassette, with one construct for each of three
reading frames. To create a targeting construct, the CFP cassette
in the desired reading frame is ligated between two regions of
homology to the gene of interest, which are generated by PCR.
The successful knock-in of a fluorescent tag requires only one
allele to be targeted, making it possible to tag endogenous proteins
in both diploid and aneuploid cell lines. We applied directed CD
tagging to label the thioredoxin 1 protein with CFP in the diploid
HCT116 cell line (data not shown), and in the aneuploind H1299
cells.
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tag, introduced into the intronic sequence as an artificial exon, is
expressed as a full-length fusion protein and serves as both a
reporter tag and a promoterless selection marker. This feature
offers several advantages. 1) It overcomes the need for a standard
drug selection marker and its subsequent excision from the
targeted gene locus by cre recombinase to restore the targeted
allele to its natural configuration [36,38,63]. 2) The artificial
exon fluorescent tag cassette can be introduced into almost any
region of the intronic sequence of interest: the subsequent
splicing into mRNA will result in correct in-frame fusion of the
tag sequence to both flanking exons. The simplicity of this
strategy contrasts with other knock-in tagging methods, where
the tag sequence is directly fused to the endogenous exon, what
requires customization of the junction point [37,38,39]. 3) The
size of exogenous DNA that can be included into rAAV targeting
vectors is limited by the packaging capacity of rAAV up to 4.8 kb
[64]. To maximize targeting efficiency, homologous arms (HAs)
must be as long as possible [65]. The standard drug selection
cassettes are ,2 kb in size. Inclusion of large tag sequences (such
as fluorescent tag cassette, which is ,0.8 kb in size) into rAAV
vector, will leave a total space of only 2 kb for two HAs,
translating to 1 kb per arm. Using fluorescent tag as a reporter
and as a selection marker overcomes these size constrains and
allows increasing the length of each HA up to 2 kb. We routinely
use HAs that are 1.6–2 kb long. 4) Although the promoterless
configuration of selection markers and utilization of rAAV as a
DNA delivery tool significantly improved the efficiency of
directed gene targeting, homologous recombination in human
cells remains a very rare event. Therefore, the proportion of
false-positive events introduced by either selection method is
relatively high. We found that in our method only 3–10% of cells
selected by FACS represent true CFP positive events, as detected
by fluorescence microscopy. This is comparable to the percent-
ages of recombinant (true-positive) clones detected among the
drug-resistant colonies when a promoterless drug resistance
marker was used for selection [34,38]. Our method offers the
advantage of rapid and easy visualization of recombinant clones
by fluorescence microscopy, reducing the number of colonies
utilized in the subsequent PCR-based screens to validate proper
targeting, down to several clones (compared to several tens or
even hundreds of clones that must be screened in the case of a
standard drug selection [34,37]).
In summary, the present directed tagging method is facile and
can yield productive cell lines from rare but precise recombination
events.
Figure 5. Both tagged and wild-type Trx and TrxR1 accumulate in the nucleus upon CPT treatment. A–D) Normalized average nuclear
levels of both tagged and wild-type Trx (cyan lines) and TrxR1 (yellow lines) increase following CPT addition. Error bars are standard error of three
independent experiments. A) Data from time-lapse movies of Trx-CFP/TrxR1-YFP cells. B) Data from images of Trx-CFP/TrxR1-YFP cells fixed at 0, 10
and 25 hours after CPT addition. C, D) Data from images of H1299 cells fixed at the same time points as above and immunostained with (C) rabbit
anti-Trx and mouse anti-TrxR1 antibodies and (D) mouse anti-Trx and rabbit anti-TrxR1 antibodies. E) Fluorescent images of live Trx-CFP/TrxR1-YFP
cells and of fixed and immunostained H1299 cells before (0h) and after (25h) CPT addition. Images of Trx-CFP/TrxR1-YFP cells represent snapshots
from the time-lapse movie. DAPI, DAPI staining used to mark nuclear boundaries in the H1299 cells. Scale bars denote 20 microns.
doi:10.1371/journal.pone.0013524.g005
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reporter cell lines
Our method allows generation of reporter cell lines which
express simultaneously several proteins of interest, where each
protein is labeled endogenously with a different fluorescent tag.
Creation of such reporter lines requires iterative rounds of directed
CD tagging. At least three different fluorescent tags (e.g. red,
yellow and cyan fluorophores) could be used simultaneously.
To generate double-labeled reporter cells we employed the
H1299 LARC collection, which already contains over a thousand
clones expressing different endogenous proteins labeled with YFP
by non-directed CD tagging. Using cells from the LARC
collection allows considerable shortening of the time required to
generate double-labeled reporter lines, since only one round of
directed tagging is required. We successfully applied this strategy
to tag the Trx protein with CFP in the LARC clone expressing the
TrxR1-YFP fusion protein. The resulting Trx-CFP/TrxR1-YFP
reporter cells were utilized to study the dynamical relationship
between Trx and TrxR1in individual living cells.
Correlated dynamics and variability in the thioredoxin
system
Here we provide a view of the thioredoxin system components,
Trx and TrxR1, in individual living cells under basal conditions
and following CPT treatment. Dynamics of Trx and TrxR1
proteins were followed at high temporal resolution and accuracy
using Trx-CFP/TrxR1-YFP reporter cells. Endogenous tagging of
both proteins preserved their native regulation, avoided overex-
pression concerns, and faithfully reported their nuclear entry and
dynamical profiles.
We found substantial correlation between the levels of Trx-CFP
and TrxR1-YFP in both the nucleus and the whole cell. These
Figure 6. Nuclear levels of both tagged and wild-type Trx and TrxR1 increase after H2O2 exposure. A) Nuclear fluorescence profile of
Trx-CFP, TrxR1-YFP and Cherry-tagged proteins following H2O2 addition. Data obtained from time-lapse movies of Trx-CFP/TrxR1-YFP cells. Error bars
denote standard error. B) Nuclear accumulation of tagged and wild-type Trx and TrxR1 upon H2O2 treatment. Average nuclear protein levels
measured before (0h) and after (6h) H2O2 addition. Blue bars, data from fixed H1299 cells immunostained for Trx and TrxR1. Red bars, data from time-
lapse movies of live Trx-CFP/TrxR1-YFP cells. C) Fluorescent images of live Trx-CFP/TrxR1-YFP cells and of fixed H1299 cells immunostained for Trx and
TrxR1 before (0h) and after (6h) H2O2 addition. Images of Trx-CFP/TrxR1-YFP cells represent snapshots from the time-lapse movie. DAPI staining is
used to mark nuclear boundaries in the H1299 cells. Scale bars denote 20 microns.
doi:10.1371/journal.pone.0013524.g006
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proteins from the same biological systems tend to be highly
correlated, whereas proteins from different systems are more
weakly correlated [1,66]. Interestingly, immunohistochemical
studies of a large set of non-small lung carcinomas also revealed
strong association between the expression levels of Trx and TrxR1
in both the nuclear and cytoplasmic compartments [59].
We further found that basal nuclear levels of both Trx-CFP and
TrxR1-YFP showed high cell-to-cell variability. This variability is
considerably higher than the variability observed for the total
levels of either of the proteins and mainly stems from cells that are
highly enriched in nuclear Trx-CFP and TrxR1-YFP even in the
absence of stress. Such variability in subcellular distribution of
both proteins within clonal cell population may be attributed, at
least in part, to the differences in micro-environments inhabited by
individual cells and/or variations in ROS levels within cells due to
variations in internal states.
There are numerous reports demonstrating nuclear transloca-
tion of Trx in response to a variety of agents causing elevation of
intracellular ROS [47,48,49,50,51,53]. However, to the best of
our knowledge, the changes in subcellular distribution of TrxR1
has not previously been reported. Here we find that following CPT
Figure 7. Trx-CFP and TrxR1-YFP are highly correlated in their response to CPT. A) Correlation of Trx-CFP and TrxR1-YFP following CPT
addition: total cell fluorescence (green) and nuclear fluorescence (blue) of Trx-CFP and TrxR1-YFP show moderate correlation (minimal correlation
values observed: R=0.58, p,0.0001, for the total cell protein levels and R=0.54, p,0.0001, for the nuclear protein levels), while nuclear enrichment
(red) is highly correlated (minimal correlation value observed: R=0.75, p,0.0001). Error bars denote standard error. B) Normalized cross correlation
function of total cell protein levels (the upper panel) and of nuclear enrichment (the lower panel) of Trx-CFP and TrxR1-YFP in unsynchronized cells
(blue lines), cell-cycle synchronized cells (red lines) and in cells exposed to CPT (green lines). Error bars denote standard error. C) T50 of Trx-CFP and
TrxR1-YFP are highly correlated (R=0.71 p,0.0001). T50 is defined as the time it takes for each protein to reach half of the total nuclear level
observed 25 hours after CPT addition. Each circle in the scatter plot represents a measurement obtained from an individual cell. Altogether 233 cells
were analyzed.
doi:10.1371/journal.pone.0013524.g007
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ROS-induced nuclear accumulation of Trx was previously shown
to be dependent on karyopherin alpha [60]. Trx, which lacks
nuclear localization signal (NLS), appears to interact with
karyopherin alpha through lysines 81 and 82. Nuclear import of
Trx is also suggested to be regulated by post-translation
modification of Trx on cysteine 69 [60]. Thus, despite its small
size (about 13 kDa), Trx does not seem to freely diffuse through
the nuclear pores, but is rather imported into the nucleus in a
regulated manner. Similarly to Trx, TrxR1 does not have NLS or
NES motifs. The mechanism of nuclear accumulation of TrxR1
still remains to be elucidated.
Analysis of individual cells revealed no dependence between the
basal nuclear levels of the two proteins and the rate of their
nuclear accumulation upon CPT addition. Similarly, no sizable
correlation was found between the basal nuclear levels and
absolute amounts of Trx/TrxR1 entering the nucleus following
CPT. Interestingly, a moderate anti-correlation between initial
nuclear levels and the relative amount of Trx/TrxR1 protein
entering the nucleus in response to CPT was observed. Put
together with considerably reduced cell-to-cell variability in
nuclear levels of both proteins after drug addition, these results
might suggest a limit to the dynamic range of nuclear
accumulation in CPT-treated cells for both Trx-CFP and
TrxR1-YFP. The present data suggest that mechanism for Trx/
TrxR1 nuclear accumulation differs from the ‘‘fold-change’’
response (where the intensity of response is proportional to the
initial protein levels), which was observed in signaling proteins
such as ERK2 [11] and beta-catenin [67]. The observed response
of the thioredoxin system more resembles an ‘‘absolute’’ response
mechanism.
The relative amount of protein located to the nucleus (nuclear
enrichment) and the rate of nuclear accumulation following CPT
addition are highly correlated between Trx and TrxR1 in
individual cells. This correlation is more pronounced than the
correlation observed for the absolute protein levels, indicating that
dynamic behavior of both proteins in response to CPT is even
more similar than their expression levels, and suggests a functional
interdependence. This functional interdependence is also reflected
by the slow decay rate of the cross correlation function calculated
for nuclear enrichment of both proteins following CPT stimulation
(in contrast to the fast decay rate observed in the absence of CPT).
The data above suggest that both proteins act in concert in
response to stress, consistent with the fact that Trx and TrxR1
function together. Nuclear translocation of Trx is an important
defense response when the cells are under unfavorable circum-
stances. It provides the necessary reducing equivalent to redox-
sensitive transcription factors like NF-kappaB [52,53], Ref-1/AP1
[54], Ref-1/p53 [55], Nrf2 [56] and HIF [57], which regulate the
expression of stress-responsive genes. In this context, the
concurrent nuclear accumulation of TrxR1 could promote
regulation of these transcription factors by maintaining reduction
of Trx in situ. This is supported by the notion that during oxidative
stress caused by glucose and glutamine deprivation, Trx in the
nuclear compartment is more protected against oxidation than in
the cytoplasm [68].
The observed concurrent nuclear accumulation of both proteins
suggests that nuclear translocation of Trx could be dependent on
TrxR1 or vice versa. To test this hypothesis we attempted to knock
down TrxR1 or Trx by means of siRNA. However, depletion of
any one of the two proteins (Trx to ,20% and TrxR1 to ,35% of
original protein level) did not alter the dynamics of nuclear
translocation of either protein. Both proteins showed dynamics
similar to those observed without the knockdown (data not shown).
One possible explanation for this observation might be that the
extent of knockdown was insufficient to alter protein behavior due
to tremendous reserve capacity in vital redox systems. This
possibility is supported by recent studies demonstrating that
reduction of TrxR1 activity by more than 90% using either siRNA
or inhibition with a gold compound aurothioglucose did not affect
the redox state of Trx and its activity, suggesting that the
remaining 10% of TrxR1 activity was sufficient to support
reduction of Trx [69,70]. Another possibility might be that
nuclear translocation of both Trx and TrxR1 is dependent on an
upstream regulator.
In summary, we presented an approach for targeted fluorescent
tagging of endogenous proteins to generate multicolor reporter cell
lines. This approach enables studies of dynamic behaviors of two
proteins within individual living cells. We used this to study two
proteins, Trx and TrxR1, constituting the thioredoxin system. We
find that Trx and TrxR1 show large variability between cells in
timing, localization and levels, but the two proteins vary between
cells in a highly correlated manner. Further implementation of this
approach would make it possible to study other systems and
pathways in individual cells and eventually lead to construction of
pathway reporter libraries to study different biological systems at
the proteomics level.
Materials and Methods
Cells and cell culture reagents
The LARC library of YFP-tagged proteins in the H1299 non-
small lung carcinoma cell line was previously described [10,25]. In
the present study we used the LARC clone 010506pl1A12 expre-
ssing the TrxR1-YFP fusion protein (www.dynamicproteomics.
net). Cells were grown in RPMI1640 medium containing L-
glutamine (21875, GIBCO) supplemented with 10% Fetal Calf
Serum and 1% Penicillin-Streptomycin (Biological Industries,
Israel).
The AAV-293 cells (Stratagene) were grown in high glucose
DMEM medium (D5796, Sigma) supplemented as above.
Construction of Trx-CFP rAAV targeting vector
1. Construction of artificial exon CFP cassette. mCeru-
lean coding sequence (with no start and stop codons) was PCR-
amplified from the Addgene plasmid 15214 using forward and
reverse primers that contained splice acceptor and donor
sequences, respectively [71]. The primers also included EcoRV
site at their 59 termini. Primers’ sequences are available upon
request. Three separate PCR reactions, one for each reading
frame, were performed. Each reading frame insert was then cloned
into EcoRV site of the pBluescript II SK(+) vector (Stratagene).
2. Generation of Trx Homologous Arms (HAs). Two
adjacent regions of homology to intron 3 of the thioredoxin 1 gene
were PCR-amplified from genomic DNA obtained from H1299
cells, using Expand High Fidelity
Plus PCR System (Roche), as per
manufacturer’s instructions. PCR primers included restriction
enzyme sites (underlined) compatible with the targeting vector
assembly. The 1476 bp left HA was amplified using forward
primer containing NotI site (ATAAGAATGCGGCCGCA-
AGTGCTGGGATTATCCACCACG) and reverse primer
containing SalI site (ACCTGTCGACTCATACGGAAGTC-
CTCGAGTGC). The 1525 bp right HA was amplified using
forward primer containing BamHI site (ACGCGGATCCAG-
AGCTCCTCCTTCATGTCTGC) and reverse primer con-
taining NotI site (ATAAGAATGCGGCCGCTAGCCTGG-
CTAACACGGAGAAAC). HAs were then treated with
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pBluescript II SK(+) vector for sequencing purposes.
3. Assembling of targeting vector. The ITR-containing
pAAV vector backbone was excised from the pAAV-MCS plasmid
(Stratagene) by cleavage with NotI and subsequent
dephosphorylation by calf intestinal alkaline phosphatase (NEB).
The CFP cassette in reading frame 0 was excised from the
pBluescript vector by treatment with SalI/BamHI. Left and right
HAs were excised from the pBluescript vector by digestion with
NotI/SalI and BamHI/NotI, respectively. The desired restriction
fragments were gel-purified using 0.8% agarose gel
electrophoresis. The DNA was recovered from the gel using the
Qiagen Gel Extraction kit. Assembling of targeting construct
composed of two Trx HAs, CFP cassette and pAAV vector
backbone was accomplished by four-part ligation using the high-
concentration T4 DNA Ligase (USB). Ligation product was
purified by ethanol precipitation, dissolved in distilled water and
electroporated into DH10B electrocompetent E.coli cells
(Invitrogen). Recombinant clones were identified by colony-PCR
using CFP-specific primers. The targeting vector DNA was
prepared using the Qiagen Plasmid Maxiprep kit. Proper
assembly of Trx-CFP rAAV targeting vector was further
confirmed by restriction digestion analysis.
Production of infectious rAAV stocks
Trx-CFP rAAV stocks were produced by co-transfection of the
targeting vector described above (5.5 mg) and 5.5 mg of each
pAAV-RC and pHelper plasmids (AAV Helper-Free System,
Stratagene) into 70% confluent AAV-293 cells grown in 15 cm
plates, using the JetPei
TM transfection reagent (Polyplus transfec-
tion) as per manufacturer’s instructions. rAAV particles were
collected 3 days post-transfection by scraping cells from one 15 cm
plate into 1 mL sterile PBS followed by 4 freeze/thaw cycles. Each
cycle consisted of 10 min freeze in a dry ice/ethanol bath, and
10 min thaw in a 37uC water bath, vortexing after each thaw. The
cell lysates were then clarified by centrifugation at 12K rpm in a
benchtop microfuge to remove cell debris, and supernatant
containing rAAV was used fresh or stored at 280uC.
In parallel with Trx-CFP rAAV stock preparation, control CFP
rAAV stock was produced by co-transfection of pAAV-CFP
reporter vector, pAAV-RC and pHelper into AAV-293 cells, as
described above. pAAV-CFP construct directing expression of
CFP from the CMV promoter was generated by cloning
mCerulean coding sequence into multiple cloning site of pAAV-
MCS plasmid. CFP fluorescence of transfected AAV-293 cells was
monitored by fluorescence microscopy to estimate transfection
efficiency.
Infection of target cells
About 10
6 cells from the TrxR1-YFP expressing LARC clone
010506pl1A12 were plated onto 10 cm dishes 24h before
infection. At the time of infection, cell medium was aspirated
and 6 ml of medium containing 1 mL of Trx-CFP rAAV stock
was added to the cells. Twenty four hours later, infected cells were
given fresh medium and grown for additional 2 days to increase
probability of homologous recombination events. During this
period, the cells were split into 15 cm plates to maintain the cell
culture under logarithmic growth.
In parallel, TrxR1-YFP cells were infected with the control CFP
rAAV stock to estimate infection efficiency. More than 75% of
cells from the control infection were CFP-positive, as determined
by FACS analysis (LSRII cell analyzer, Becton Dickinson).
Note that use of crude (low-titer) rAAV lysates is thought to lead
to a very low probability of multiple genomic integration events in
the same cell [36].
Selection of recombinant cells by FACS and clone
expansion
Following infection with Trx-CFP rAAV, the cells were
harvested by trypsinization, washed twice with sterile calcium/
magnesium-free PBS, re-suspended in cold PBS at ,2610
6 cells/
ml and filtered through a 50 mM mesh to generate a single-cell
suspension. Afterwards, the cells were sorted on a FACSAriaII cell
sorter (Becton Dickinson). Uninfected parental TrxR1-YFP cells
were used as a negative control to determine the gating region to
be used for selection of CFP-positive cells. Single CFP-positive
recombinant cells were collected into individual wells of 384-well
plastic optical plates (781091, Greiner Bio-One). The clones were
expanded from single cells by incubating the plates for 10–14 days
until the cells are confluent (the medium was changed every 3–4
days). During this period, the clones were further screened for CFP
expression by fluorescence microscopy to detect true-positive
events. Note that microscopic screen can also be performed
following FACS sorting, immediately after the cells are spread out.
However for the reasons of convenience and feasibility of the
screen we recommend performing it after the cells form visible
colonies. Confluent CFP-positive clones were then transferred
from a 384-well plate to three 96 well plates and grown to
confluence. Cells from two plates were frozen as previously
described [25], cells from the third plate were used for 39RACE
and RT-PCR analyses to confirm proper targeting.
39RACE
39RACE analysis was performed essentially as described in Sigal
et al. [25]. Total RNA was isolated from recombinant clones grown
to confluence in a 96-well plate using ZR-96 mini RNA isolation I
kit (Zymo Research). First-strand cDNA was synthesized from
1 mg total RNA using Omniscript RT Kit (Qiagen) and (dT)17-AP
primer (GGCCACGCGTCGACTAGTAC(T)17). cDNA contain-
ing the CFP tag sequence was amplified by nested PCR using
Ready-Mix PCR mix (Bio-Lab). The first PCR reaction was
performed with AP primer lacking (dT)17 and mCerulean-specific
primer f432 spanning nucleotides 432–451 (CAACGCCAT-
CAGCGACAACG). The second (nested) PCR reaction was
performed using the AP primer above and mCerulean-specific
primer f606 spanning nucleotides 606–626 (GAGCACCCAGTC-
CAAGCTGAG). PCR products were purified by QIAquick PCR
purification kit (Qiagen) and sequenced using the f606 primer.
RT-PCR
Total RNA was isolated as described above. First-strand cDNA
template was generated from 1 mg total RNA in a 20 mL reaction
using oligo(dT)15 primer (Promega) and Omniscript RT Kit
(Qiagen), as per manufacturer’s instructions. Primer-specific
cDNA was PCR-amplified using Ready-Mix PCR mix (Bio-
Lab). mRNA expressed from both the CFP tagged and wild-type
Trx alleles was detected using the forward primer f1Trx
(AGCAGATCGAGAGCAAGACTG), which anneals in exon1
of Trx cDNA, and the reverse primer bTrx (CAGATGG-
CAACTGGGTTTATG), which anneals in exon 5. CFP-tagged
Trx mRNA was detected using the forward primer f2Trx
(AGTTGACTTCTCAGCCACGTG), which anneals in exon 2
of Trx cDNA, and the reverse primer bCFP (CTTGTA-
CAGCTCGTCCATGC) annealing in the 39 end of CFP
sequence. Another primer pair used was the forward primer fCFP
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end of CFP sequence and the reverse primer bTrx (see above).
Immunoblot analysis
Total cell lysates from the control H1299 cell line, the parental
TrxR1-YFP clone, and double-labeled Trx-CFP/TrxR1-YFP cells
were prepared using RIPA buffer (Pierce) according to manufac-
turer’s instructions. Protein concentrations were determined by
BCA protein assay kit (Pierce). Total protein (15mg) was resolved
on SDS-PAGE and transferred to Hybond-ECL nitrocellulose
membrane (Amersham Biosciences). The membranes were then
immunoblotted with anti-GFP, -Trx or -TrxR1 primary antibod-
ies followed by HRP-conjugated secondary antibodies (Amersham
Biosciences). Protein bands were visualized by ECL Western
Blotting Detection Reagent (Amersham Biosciences). Intensity of
protein bands was quantified using ImageJ software.
Mouse anti-GFP antibody (11814460001) was obtained from
Roche and used at dilution 1:600. The following antibodies were
purchased from Santa Cruz: mouse anti-TrxR1 (sc-28321), rabbit
anti-TrxR1 (sc-20147), mouse anti-Trx (sc-58441) and rabbit anti-
Trx (sc-20146). Mouse antibodies were used at dilution 1:150,
rabbit antibodies were diluted 1:250.
Cell treatment with CPT and H2O2
Camptothecin (CPT, C9911, Sigma) was dissolved in DMSO
(D2650, Sigma) to obtain a stock solution of 10mM. In each
experiment the drug was diluted to 10 mM in complete cell
medium, and cell growth medium was replaced by the diluted
drug. In time-lapse movies, the medium (2mL) was replaced under
the microscope after at least 5 rounds of images taken before drug
addition.
Hydrogen Peroxide solution (H2O2, 30%) was obtained from
J.T.Baker. To prepare stock solution, H2O2 was diluted 1:500 in
sterile PBS. Stock concentration was determined by a spectro-
photometric method as described previously [72]. H2O2 concen-
tration in the stock solution was about 20 mM. Immediately
before addition to the cell culture, H2O2 stock was diluted in
complete cell medium to a final concentration of 80 mM. Cell
treatment with H2O2 was carried out as described above.
Immunofluorescence
H1299 cells grown on fibronectin-coated coverslips were fixed
with 3% paraformaldehyde in PBS for 20 min at room
temperature and permeabilized with 0.5% Triton X-100 in
PBS for 5 min. The cells were then blocked for 1h with 2% BSA
in PBS and incubated for 1h with primary antibodies diluted
1:100 in 2% BSA/PBS. Two pairs of primary antibodies (Santa
Cruz) were used: mouse anti-Trx (sc-58441)/rabbit anti-TrxR1
(sc-20147) and rabbit anti-Trx (sc-20146)/mouse anti-TrxR1 (sc-
28321). After washing in PBS the cells were incubated for 1h with
fluorchrome-conjugated secondary antibodies: Cy3-conjugated
goat anti-rabbit (1:400, Jackson Immunoresearch) and Alexa
Fluor 488-conjugated goat anti-mouse (1:200, Molecular Probes).
49-6-Diamidino-2-phenylindole-2HCl (DAPI, D9542, Sigma)
was used at a concentration of 0.05mg/mL for 30 min as a
nuclear counterstain. The cells were then washed with PBS and
mounted in Elvanol (Mowiol 4–88, Hoechst, Germany). Images
were acquired with Leica DMIRE2 inverted fluorescence
microscope at 206 magnification using appropriate filter sets.
Image analysis was performed with custom-written software
described below. In each experiment, about 500 cells were
analyzed per condition.
Time-lapse microscopy
Time-lapse movies were obtained at 206 magnification as
described in Sigal et al. [28] with an automated, incubated
(including humidity and CO2 control) Leica DMIRE2 inverted
fluorescence microscope and an ORCA ER cooled CCD camera
(Hamamatsu Photonics). The system was controlled by ImagePro5
Plus (Media Cybernetics) software which integrated time-lapse
acquisition, stage movement, and software based auto-focus.
During the experiment, cells were grown and visualized in 12-
well coverslip bottom plates (MatTek) coated with 10mM
fibronectin (Sigma). The standard RPMI medium was replaced
with RPMI without phenol red (Biological Industries, Israel) to
decrease autofluorescence. For each well, time-lapse movies were
obtained at four fields of view. Each movie was taken at a time
resolution of 20 minutes and was filmed for at least 30 hours (over
90 time points). Each time point included four images: phase
contrast; red, yellow and cyan fluorescence. For an example see
Movies S1, S2, S3, S4.
Image analysis of time-lapse movies
We used custom image analysis software described in Cohen
et al. [10] with some modifications to allow measurements of 3
different fluorescent colors. The main steps in this software
include: background correction (flat field correction and back-
ground subtraction), cellular and nuclear segmentation, cell
tracking, and automated identification of cell division events. No
significant bleaching was observed (on average less than 3% over
the duration of the experiment). Cell and nuclei segmentation was
based on the red fluorescent images of mCherry-tagged proteins
common to all LARC clones, whose expression creates fluores-
cence pattern which is bright in the nucleus and dimmer in the
cytosol and is relatively uniform across the cells. Global image
threshold computed according to Otsu’s method [73] was used to
differentiate between cell boundaries and background. Segmenta-
tion of neighboring cells was performed by applying the seeded
watershed segmentation algorithm. Seeds were obtained by
smoothening of the red intensity image and usage of the nuclei
as cell seeds. For nuclei segmentation red fluorescence intensity of
each cell was stretched between zero and one and a fixed threshold
was used to differentiate between the nucleus and the cytoplasm.
Cell tracking was performed by analysis of the movie from end to
start and linking each segmented cell to the cell in the previous
image with the closest centroid. Cell division events were identified
automatically using in-silico synchronization as described in Sigal
et al. [28]. In short, cell division was detected by a sharp twofold
drop in total fluorescence level between consecutive images.
Comparison of tagged and parental clones
We compared the morphology, cell cycle duration and motility
of the precursor H1299 cells tagged with Cherry only, the parental
TrxR1-YFP cells and the Trx-CFP/TrxR1-YFP double tagged
cells, using time-lapse microscopy. We find that the motility (mean
velocity of center of mass) of H1299-Cherry, TrxR1-YFP and Trx-
CFP/TrxR1-YFP cells was 8.660.5, 8.260.5 and 8.460.6 mi-
crons/hour, respectively (the data represent mean 6 standard
error); duration of cell-cycle was 2764, 2965 and 2963 hours,
respectively, and the clones had undistinguishable cell
morphology.
Cross correlation calculation
The cross correlation function r(t) was calculated using the
following equation:
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c(t) and y(t) denote measurements of CFP and YFP fluorescence,
respectively, at time t in an individual cell;  c c and  y y denote the
average CFP and YFP fluorescence at time t, and STi denote
average over cells. r(t) was calculated for total cell fluorescence
and nuclear enrichment in unsynchronized cells, cells synchro-
nized to the cell-cycle in silico, and CPT treated cells.
Supporting Information
Figure S1 Normalized basal distributions of whole cell levels (A)
and nuclear levels (B) of Trx-CFP (cyan line), TrxR1-YFP (yellow
line) and Cherry (red line). Protein distribution profiles were
normalized to 1 by dividing the protein level of each cell by the
average protein level of all cells. A fraction of cells highly enriched
in nuclear Trx-CFP/TrxR1-YFP is represented by a long right
tail. Error bars denote standard error.
Found at: doi:10.1371/journal.pone.0013524.s001 (0.36 MB TIF)
Figure S2 A–B) No correlation is observed between the initial
nuclear level (Fi) of TrxR1-YFP (A) or Trx-CFP (B) and the
absolute amount of protein entering the nucleus upon CPT
addition. The absolute amount is defined as the difference
between the maximal (within 25 hours following CPT addition)
and initial nuclear levels (Fmax-Fi) of either protein. C–D)
Moderate anti-correlation is observed between Fi and the relative
amount of protein entering nucleus (Fmax/Fi). For TrxR1
R=20.3 p,0.0001, Trx R=20.41, p,0.0001. Robustness of
correlation values was checked by bootstrapping. Each circle in
the scatter plot represents a measurement obtained from an
individual cell for TrxR1-YFP (yellow circles) or for Trx (cyan
circles). Altogether 303 cells were analyzed.
Found at: doi:10.1371/journal.pone.0013524.s002 (1.39 MB TIF)
Figure S3 Total cell levels of Trx-CFP and TrxR1-YFP do not
change significantly upon CPT addition, while cytoplasmic levels
slightly decrease. Normalized average total cell fluorescence (A)
and cytoplasmic fluorescence (B) profiles of Trx-CFP (cyan line)
and of TrxR1-YFP (yellow line) are shown. Cell-to-cell variability
in total cell fluorescence (C) and cytoplasmic fluorescence (D) of
both Trx-CFP and TrxR1-YFP shows no considerable changes
following CPT addition. CV, coefficient of variance. Error bars
denote standard error of three independent experiments.
Found at: doi:10.1371/journal.pone.0013524.s003 (0.91 MB TIF)
Figure S4 A) Nuclear enrichment of both Trx-CFP (cyan line)
and TrxR1-YFP (yellow line) increases after CPT addition. B) CV
of nuclear enrichment for both Trx-CFP and TrxR1-YFP
decreases following CPT addition. Error bars represent standard
error.
Found at: doi:10.1371/journal.pone.0013524.s004 (1.27 MB TIF)
Figure S5 Trx and TrxR1 proteins labeled with a fluorescent
tag at different locations show similar dynamics of nuclear
accumulation upon CPT treatment. A) Trx nuclear enrichment.
Blue line, average nuclear enrichment of Trx-CFP from the Trx-
CFP/TrxR1-YFP clone (CFP is inserted into intron 3 of the
thioredoxin gene); red line, average nuclear enrichment of Trx-
YFP from the LARC clone 160507pl1F3 (YFP is inserted into
intron 1 of the thioredoxin gene). B) TrxR1 nuclear enrichment.
Red line, average nuclear enrichment of TrxR1-YFP from the
Trx-CFP/TrxR1-YFP clone; blue line, average nuclear enrich-
ment of TrxR1-YFP from the parental LARC clone
010506pl1A12; black line, average nuclear enrichment of
TrxR1-YFP from the LARC clone 130207pl1E3, generated by
an independent round of CD-tagging. Error bars denote standard
error.
Found at: doi:10.1371/journal.pone.0013524.s005 (1.45 MB TIF)
Figure S6 Correlation between protein levels of Trx and TrxR1
is significantly higher than that observed with the Cherry-tagged
(control) proteins. Correlations between total cell levels, nuclear
levels and nuclear enrichment of Trx-CFP, TrxR1-YFP and
Cherry are shown. Black bars represent correlation between Trx
and TrxR1, grey bars- between Trx and Cherry, white bars-
between TrxR1 and Cherry. Error bars denote standard error. P-
values are less than 0.001.
Found at: doi:10.1371/journal.pone.0013524.s006 (0.24 MB TIF)
Figure S7 Low correlation is found between (A) T50 of Trx-
CFP and Cherry (R=0.23 p,0.001) and (B) T50 of TrxR1-YFP
and Cherry (R=0.20 p,0.001). T50 is defined as the time it takes
for each protein to reach half of the total nuclear level observed
25 hours after CPT addition. Each circle in the scatter plot
represents a measurement obtained from an individual cell.
Altogether 233 cells were analyzed.
Found at: doi:10.1371/journal.pone.0013524.s007 (0.88 MB TIF)
Figure S8 No correlation is observed between basal nuclear
levels of either protein (Trx-CFP or TrxR1-YFP) and rate of their
nuclear accumulation following CPT. Rate of nuclear accumula-
tion is denoted as T50.
Found at: doi:10.1371/journal.pone.0013524.s008 (1.12 MB TIF)
Movie S1 Time-lapse movie of cyan fluorescence images of Trx-
CFP/TrxR1-YFP reporter cells. Movie duration is 38 hours,
2 hours before drug addition followed by 36 hours after drug
addition (time-lapse: 1 frame per 20 min).
Found at: doi:10.1371/journal.pone.0013524.s009 (4.53 MB AVI)
Movie S2 Time-lapse movie of yellow fluorescence images of
Trx-CFP/TrxR1-YFP reporter cells. Movie duration is 38 hours,
2 hours before drug addition followed by 36 hours after drug
addition (time-lapse: 1 frame per 20 min).
Found at: doi:10.1371/journal.pone.0013524.s010 (4.17 MB AVI)
Movie S3 Time-lapse movie of red fluorescence images of Trx-
CFP/TrxR1-YFP reporter cells. Movie duration is 38 hours,
2 hours before drug addition followed by 36 hours after drug
addition (time-lapse: 1 frame per 20 min).
Found at: doi:10.1371/journal.pone.0013524.s011 (1.99 MB AVI)
Movie S4 Time-lapse movie of transmitted light images of Trx-
CFP/TrxR1-YFP reporter cells. Movie duration is 38 hours,
2 hours before drug addition followed by 36 hours after drug
addition (time-lapse: 1 frame per 20 min).
Found at: doi:10.1371/journal.pone.0013524.s012 (5.17 MB AVI)
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